Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Secretory Leukocyte Protease Inhibitor and Helicobacter pylori in the Gastrointestinal Tract of HIV-infected Persons: A Review
The Internet Journal of Gastroenterology, 07/02/09
Chattopadhyay A et al. - Prevalence/incidence of Helicobater pylori (Hp) is reduced in HIV/AIDS. HIV-infection may alter the prevalence/incidence or pathology of Helicobacter pylori (Hp) infection. Secretory leukocyte protease inhibitor (SLPI) is an important broad spectrum innate immunity component that has anti-bacterial and HIV-1 inhibitory activity in different mucosal secretions and possibly in the local mucosal tissue milieu.
Related Articles
Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09
Relevance Score: 95%
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Relevance Score: 95%
Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09
Relevance Score: 94%
Sperm May Play Leading Role In Spreading HIV
ScienceDaily, 10/27/09
Relevance Score: 94%
Female sex work and HIV risks in Croatia
AIDS Care, 10/29/09
Relevance Score: 93%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Predictors of sub-clinical enterovirus infections in infants: a prospective cohort study
International Journal of Epidemiology, 11/30/09
Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia
Clinical Microbiology and Infection, 11/30/09
The microbial organ in the gut as a driver of homeostasis and disease
Medical Hypotheses, 11/30/09
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Macronutrient Supplementation and Food Prices in HIV Treatment
The Journal of Nutrition, 11/30/09
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy
Journal of Thrombosis and Haemostasis, 11/30/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/30/09
Article Search
Sponsor


See Latest Articles


